BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA; Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625-633. [PMID: 28240805 DOI: 10.1002/lt.24750] [Cited by in Crossref: 236] [Cited by in F6Publishing: 249] [Article Influence: 59.0] [Reference Citation Analysis]
Number Citing Articles
1 Hou W, Wu J, Wang K, Wang Z, Wang Z, Chen F, Yu H, Meng Q. Sarcopenia is associated with reduced 5-year survival in cirrhotic patients with age ≥ 65 and Child-Pugh score ≥ 7.. [DOI: 10.21203/rs.3.rs-2251805/v1] [Reference Citation Analysis]
2 Xu Z, Luo J, Yang D, Xu H, Jia J, Yang Z. Agreement and correlation of abdominal skeletal muscle area measured by CT and MR imaging in cirrhotic patients. BMC Med Imaging 2022;22:205. [DOI: 10.1186/s12880-022-00932-0] [Reference Citation Analysis]
3 Choi C, Simonetto DA. Digital interventions in the management of advanced liver disease: Prescription and monitoring of healthy living in homes. Clinical Liver Disease 2022;20:162-165. [DOI: 10.1002/cld.1253] [Reference Citation Analysis]
4 Goffaux A, Delorme A, Dahlqvist G, Lanthier N. Improving the prognosis before and after liver transplantation: Is muscle a game changer? World J Gastroenterol 2022; 28(40): 5807-5817 [DOI: 10.3748/wjg.v28.i40.5807] [Reference Citation Analysis]
5 Shafaat O, Liu Y, Jackson KR, Motter JD, Boyarsky BJ, Latif MA, Yuan F, Khalil A, King EA, Zaheer A, Summers RM, Segev DL, Mcadams-demarco M, Weiss CR. Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes. Radiology 2022. [DOI: 10.1148/radiol.212403] [Reference Citation Analysis]
6 Mehtani R, Premkumar M, Kulkarni AV. Nutrition in Critical Care Hepatology. Curr Hepatology Rep 2022. [DOI: 10.1007/s11901-022-00586-0] [Reference Citation Analysis]
7 Kang M, Lee Y, Song J, Kweon Y, Tak W, Jang S, Park J, Park S. Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19. Diagnostics 2022;12:2255. [DOI: 10.3390/diagnostics12092255] [Reference Citation Analysis]
8 Hentschel F, Schwarz T, Lüth S, Schreyer AG. Psoas muscle index predicts time to rehospitalization in liver cirrhosis: An observational study. Medicine (Baltimore) 2022;101:e30259. [PMID: 36086704 DOI: 10.1097/MD.0000000000030259] [Reference Citation Analysis]
9 Motsiuk VM, Pentiuk NO. Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis. Rep of Morph 2022;28:5-13. [DOI: 10.31393/morphology-journal-2022-28(3)-01] [Reference Citation Analysis]
10 Hou J, Zhang Y, Qiang Z, Zhu L, Zheng H, Shen Z. The psoas muscle depletion index is related to the degree of cirrhosis and skeletal muscle loss in patients with end-stage liver disease. AGEB 2022;85:453-462. [DOI: 10.51821/85.3.10110] [Reference Citation Analysis]
11 Yang C, Xiong B. A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement. Portal Hypertension & Cirrhosis 2022;1:133-144. [DOI: 10.1002/poh2.28] [Reference Citation Analysis]
12 Dhariwal S, Roy A, Taneja S, Bansal A, Gorsi U, Singh S, De A, Verma N, Premkumar M, Duseja A, Dhiman R, Singh V. Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY). J Clin Gastroenterol 2022. [PMID: 35943413 DOI: 10.1097/MCG.0000000000001745] [Reference Citation Analysis]
13 Lowe R, Hey P, Sinclair M. The sex-specific prognostic utility of sarcopenia in cirrhosis. J Cachexia Sarcopenia Muscle 2022. [PMID: 35945660 DOI: 10.1002/jcsm.13059] [Reference Citation Analysis]
14 van Dijk AM, Coppens BJP, van Beers MA, Bruins Slot AS, Verstraete CJR, de Bruijne J, Vleggaar FP, van Erpecum KJ. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome. Eur J Intern Med 2022:S0953-6205(22)00250-3. [PMID: 35902333 DOI: 10.1016/j.ejim.2022.07.002] [Reference Citation Analysis]
15 Jin R, Wang X, Li X, Yang J, Liu B, Wei L, Liu F, Rao H. Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.919502] [Reference Citation Analysis]
16 Wang Y, Shen W, Huang F, Yu C, Xi L, Gao J, Yin M, Liu X, Lin J, Liu L, Zhang H, Zhu J, Hong Y. HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis. J Int Med Res 2022;50:3000605221109385. [PMID: 35836382 DOI: 10.1177/03000605221109385] [Reference Citation Analysis]
17 Schlansky B, Farsad K. Sarcopenia of Cirrhosis and the Therapeutic Potential of Transjugular Intrahepatic Portosystemic Shunt Creation. Digestive Disease Interventions 2022;06:148-154. [DOI: 10.1055/s-0041-1742214] [Reference Citation Analysis]
18 Chon HY, Lee TH. Liver Cirrhosis and Sarcopenia. Ann Clin Nutr Metab 2022;14:2-9. [DOI: 10.15747/acnm.2022.14.1.2] [Reference Citation Analysis]
19 Hui Y, Cui B, Wang X, Sun M, Li Y, Yang W, Guo G, Mao L, Yu Z, Fan X, Sun C. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis 2022;1:42-56. [DOI: 10.1002/poh2.10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Khan S, Benjamin J, Maiwall R, Tripathi H, Kapoor PB, Shasthry V, Saluja V, Agrawal P, Thapar S, Kumar G. Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis. J Clin Transl Res 2022;8:200-8. [PMID: 35813898] [Reference Citation Analysis]
21 Ge J, Kim WR, Lai JC, Kwong AJ. "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. J Hepatol 2022;76:1318-29. [PMID: 35589253 DOI: 10.1016/j.jhep.2022.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
23 Nguyen M, Mukaneza Y, Tremblay M, Huard G, Tang A, Rose CF, Bémeur C. Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation. CanLivJ. [DOI: 10.3138/canlivj-2021-0042] [Reference Citation Analysis]
24 Reese T, Galavics C, Schneider M, Brüning R, Oldhafer KJ. Sarcopenia influences the kinetic growth rate after ALPPS. Surgery 2022. [DOI: 10.1016/j.surg.2022.04.022] [Reference Citation Analysis]
25 Marta H, Elba L, Lucía G, Santiago B, Luis R, Carlos FC, Christie P, Marta L, Luis MJ, Natalia F, Enrique VDB, Ana R, Luis CJ. A NOMOGRAM AS AN INDIRECT METHOD TO IDENTIFY SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100723] [Reference Citation Analysis]
26 Mohta S, Anand A, Sharma S, Qamar S, Agarwal S, Gunjan D, Singh N, Madhusudhan KS, Pandey RM, Saraya A. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia. Hepatol Int 2022. [PMID: 35469091 DOI: 10.1007/s12072-022-10334-7] [Reference Citation Analysis]
27 Marasco G, Dajti E, Serenari M, Alemanni LV, Ravaioli F, Ravaioli M, Vestito A, Vara G, Festi D, Golfieri R, Cescon M, Renzulli M, Colecchia A. Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis. Cancers (Basel) 2022;14:1935. [PMID: 35454842 DOI: 10.3390/cancers14081935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Quinlan JI, Jones C, Bissonnette E, Dhaliwal A, Williams F, Choudhary S, Breen L, Lavery GG, Armstrong MJ, Elsharkawy AM, Lord JM, Greig CA. The Impact of Slice Interval and Equation on the Accuracy of Magnetic Resonance Image Estimation of Quadriceps Muscle Volume in End Stage Liver Disease. Front Rehabilit Sci 2022;3. [DOI: 10.3389/fresc.2022.854041] [Reference Citation Analysis]
29 Ebadi M, Dunichand-hoedl AR, Rider E, Kneteman NM, Shapiro J, Bigam D, Dajani K, Mazurak VC, Baracos VE, Montano-loza AJ. Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100495] [Reference Citation Analysis]
30 Luengpradidgun L, Chamroonkul N, Sripongpun P, Kaewdech A, Tanutit P, Ina N, Piratvisuth T. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients. BMC Gastroenterol 2022;22:159. [PMID: 35354434 DOI: 10.1186/s12876-022-02236-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu J, Ma J, Yang C, Chen M, Shi Q, Zhou C, Huang S, Chen Y, Wang Y, Li T, Xiong B. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement. Radiology 2022;:211172. [PMID: 35289658 DOI: 10.1148/radiol.211172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Quinlan JI, Dhaliwal A, Williams F, Allen SL, Breen L, Greig CA, Lord JM, Armstrong MJ, Elsharkawy AM. Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease. Front Physiol 2021;12:817152. [PMID: 35242045 DOI: 10.3389/fphys.2021.817152] [Reference Citation Analysis]
33 Mauro E, Diaz JM, Garcia-Olveira L, Spina JC, Savluk L, Zalazar F, Saidman J, De Santibañes M, Pekolj J, De Santibañes E, Crespo G, Abraldes JG, Gadano A. Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list. Hepatol Commun 2022. [PMID: 35238487 DOI: 10.1002/hep4.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Anand A, Nambirajan A, Kumar V, Agarwal S, Sharma S, Mohta S, Gopi S, Kaushal K, Gunjan D, Singh N, Madhusudhan KS, Chauhan SS, Sharma MC, Bansal VK, Saraya A. Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:510-8. [DOI: 10.1016/j.jceh.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery RB. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions. World J Gastroenterol 2022; 28(4): 432-448 [DOI: 10.3748/wjg.v28.i4.432] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
37 Di Cola S, Nardelli S, Ridola L, Gioia S, Riggio O, Merli M. Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy. J Clin Med 2022;11:611. [PMID: 35160063 DOI: 10.3390/jcm11030611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zhang B, Cai W, Gao F, Lin X, Qian T, Gu K, Song B, Chen T. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study. Med Sci Monit 2022;28:e934057. [PMID: 35031594 DOI: 10.12659/MSM.934057] [Reference Citation Analysis]
39 Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M, Pelle G, Ridola L. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2021.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Toniutto P, Fornasiere E, Fumolo E, Bitetto D. Evaluation Process of the Liver Transplant Recipient. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wang S, Tandon P. The Impact of Sarcopenia, Frailty, and Malnutrition on Further Decompensation. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_50] [Reference Citation Analysis]
42 Singal AK, Kamath PS. Management of the Patient on the Waiting List, Scoring Systems, and Priority. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_9] [Reference Citation Analysis]
43 Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, Madhusudhan KS, Singh N, Saraya A. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:52-60. [DOI: 10.1016/j.jceh.2021.03.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Dhaliwal A, Williams FR, Quinlan JI, Allen SL, Greig C, Filer A, Raza K, Ghosh S, Lavery GG, Newsome PN, Choudhary S, Breen L, Armstrong MJ, Elsharkawy AM, Lord JM. Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study. Skelet Muscle 2021;11:27. [PMID: 34895316 DOI: 10.1186/s13395-021-00282-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Liu C, Habig G, Smaltz C, Halegoua-demarzio D. Sarcopenia in Non-alcoholic Steatohepatitis (NASH). Curr Hepatology Rep 2021;20:117-127. [DOI: 10.1007/s11901-021-00572-y] [Reference Citation Analysis]
46 Yang W, Wang X, Yu Z, Li C, Sun M, Li Y, Hui Y, Guo G, Fan X, Jiang K, Sun C. Low Levels of Serum Zinc Associate with Malnutrition Risk Assessed by the Royal Free Hospital-Nutritional Prioritizing Tool in Cirrhosis. Biol Trace Elem Res 2021. [PMID: 34791623 DOI: 10.1007/s12011-021-03033-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Guarino M, Cossiga V, Becchetti C, Invernizzi F, Lapenna L, Lavezzo B, Lenci I, Merli M, Pasulo L, Zanetto A, Burra P, Morisco F; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature. Dig Liver Dis 2021:S1590-8658(21)00811-2. [PMID: 34789397 DOI: 10.1016/j.dld.2021.10.010] [Reference Citation Analysis]
48 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
49 Chong J, Guorgui J, Coy H, Ito T, Lu M, DiNorcia J, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Perioperative Skeletal Muscle Fluctuations in High-Acuity Liver Transplantation. J Surg Res 2021;270:386-93. [PMID: 34739998 DOI: 10.1016/j.jss.2021.09.030] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Alexopoulos T, Vasilieva L, Kontogianni MD, Tenta R, Georgiou A, Stroumpouli E, Mani I, Alexopoulou A. Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia. Am J Physiol Gastrointest Liver Physiol 2021;321:G543-51. [PMID: 34469188 DOI: 10.1152/ajpgi.00184.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Tsao YT, Lee WC, Huang CH, Lin IH, Huang YY. A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant. J Formos Med Assoc 2021:S0929-6646(21)00461-7. [PMID: 34666924 DOI: 10.1016/j.jfma.2021.09.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ito T, Guorgui J, Markovic D, Coy H, Younan SM, DiNorcia J 3rd, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Sarcopenia in high acuity liver transplantation: Does it predict outcomes? Clin Transplant 2021;:e14503. [PMID: 34634157 DOI: 10.1111/ctr.14503] [Reference Citation Analysis]
53 Bunchorntavakul C, Reddy KR. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately-authors' reply. Aliment Pharmacol Ther 2021;54:983-4. [PMID: 34506657 DOI: 10.1111/apt.16581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Panchal S, Serper M, Bittermann T, Asrani SK, Goldberg DS, Mahmud N. Impact of Race-Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver-Kidney Transplantation. Liver Transpl 2021. [PMID: 34558791 DOI: 10.1002/lt.26310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Gioia S, Ridola L, Cristofaro L, Merli M, Faccioli J, Riggio O, Nardelli S. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int 2021;41:2965-73. [PMID: 34543504 DOI: 10.1111/liv.15060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
56 Boster JM, Saiman Y. Nutritional Management of Sarcopenia in Chronic Liver Disease. Curr Treat Options Gastro 2021;19:509-523. [DOI: 10.1007/s11938-021-00356-9] [Reference Citation Analysis]
57 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 61.0] [Reference Citation Analysis]
58 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Cho YS, Lee HY, Jeong JY, Lee JG, Kim TY, Nam SW, Sohn JH. Computed Tomography-Determined Body Composition Abnormalities Usefully Predict Long-term Mortality in Patients With Liver Cirrhosis. J Comput Assist Tomogr 2021;45:684-90. [PMID: 34407059 DOI: 10.1097/RCT.0000000000001207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Siddiqui ATS, Parkash O, Hashmi SA. Malnutrition and liver disease in a developing country. World J Gastroenterol 2021; 27(30): 4985-4998 [PMID: 34497430 DOI: 10.3748/wjg.v27.i30.4985] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Sidhu SS, Saggar K, Goyal O, Varshney T, Kishore H, Bansal N, Sidhu SS. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol 2021;33:555-64. [PMID: 32433422 DOI: 10.1097/MEG.0000000000001761] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
62 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl 2021;27:1041-53. [PMID: 33713382 DOI: 10.1002/lt.26052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
64 Feng H, Wang X, Mao L, Yu Z, Cui B, Lin L, Hui Y, Zhao X, Xu X, Fan X, Wang B, Yu Q, Jiang K, Sun C. Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis. Ther Adv Chronic Dis 2021;12:20406223211026996. [PMID: 34377386 DOI: 10.1177/20406223211026996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
65 Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, Raszeja-Wyszomirska J. Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients. Life (Basel) 2021;11:740. [PMID: 34440484 DOI: 10.3390/life11080740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
67 Nardelli S, Gioia S, Ridola L, Carlin M, Cioffi AD, Merli M, Riggio O, Spagnoli A. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more? Dig Liver Dis 2021:S1590-8658(21)00333-9. [PMID: 34233863 DOI: 10.1016/j.dld.2021.06.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Alsebaey A, Sabry A, Rashed HS, Elsabaawy MM, Ragab A, Aly RA, Badran H. MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation. Asian Pac J Cancer Prev 2021;22:2005-9. [PMID: 34319020 DOI: 10.31557/APJCP.2021.22.7.2005] [Reference Citation Analysis]
69 Pinto Dos Santos D, Kloeckner R, Koch S, Hoppe-Lotichius M, Zöller D, Toenges G, Kremer WM, Zimmermann T, Mittler J, Lang H, Düber C, Galle PR, Weinmann A, Sprinzl MF. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020;32:626-34. [PMID: 31725030 DOI: 10.1097/MEG.0000000000001552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
70 Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
71 Ha NB, Cho SJ, Mohamad Y, Kent D, Jun G, Wong R, Swarnakar V, Lin S, Maher JJ, Lai JC. Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis. Dig Dis Sci 2021. [PMID: 34136974 DOI: 10.1007/s10620-021-07099-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Li T, Xu M, Kong M, Song W, Duan Z, Chen Y. Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure. Sci Rep 2021;11:12593. [PMID: 34131260 DOI: 10.1038/s41598-021-92087-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Woodward AJ, Wallen MP, Ryan J, Ward LC, Coombes JS, Macdonald GA. Evaluation of techniques used to assess skeletal muscle quantity in patients with cirrhosis. Clin Nutr ESPEN 2021;44:287-96. [PMID: 34330481 DOI: 10.1016/j.clnesp.2021.05.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
74 Kang MK, Baek JH, Kweon YO, Tak WY, Jang SY, Lee YR, Hur K, Kim G, Lee HW, Han MH, Choi JH, Park SY, Park JG. Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. Diagnostics (Basel) 2021;11:1061. [PMID: 34207587 DOI: 10.3390/diagnostics11061061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
75 Duong N, Sadowski B, Rangnekar AS. The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes. Clin Liver Dis (Hoboken) 2021;17:271-6. [PMID: 33968388 DOI: 10.1002/cld.1043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Armstrong MJ, Lai JC. Frailty and the Potential Liver Transplant Candidate. Liver Transplantation 2021. [DOI: 10.1002/9781119634010.ch4] [Reference Citation Analysis]
78 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
79 Nachit M, Kwanten WJ, Thissen JP, Op De Beeck B, Van Gaal L, Vonghia L, Verrijken A, Driessen A, Horsmans Y, Francque S, Leclercq IA. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. J Hepatol 2021;75:292-301. [PMID: 33865909 DOI: 10.1016/j.jhep.2021.02.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 21.0] [Reference Citation Analysis]
80 Habig G, Smaltz C, Halegoua-DeMarzio D. Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis. Metabolites 2021;11:242. [PMID: 33920751 DOI: 10.3390/metabo11040242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Mazzola A, Brustia R, Magro B, Atif M, Ouali N, Tourret J, Barrou B, Scatton O, Conti F. Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study. Clin Res Hepatol Gastroenterol 2021;45:101692. [PMID: 33848672 DOI: 10.1016/j.clinre.2021.101692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Orkin S, Yodoshi T, Romantic E, Hitchcock K, Arce-Clachar AC, Bramlage K, Sun Q, Fei L, Xanthakos SA, Trout AT, Mouzaki M. Body composition measured by bioelectrical impedance analysis is a viable alternative to magnetic resonance imaging in children with nonalcoholic fatty liver disease. JPEN J Parenter Enteral Nutr 2021. [PMID: 33811369 DOI: 10.1002/jpen.2113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
83 Ohashi K, Ishikawa T, Hoshii A, Hokari T, Noguchi H, Suzuki M, Hirosawa H, Imai M, Mitobe Y, Yoshida T. Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease. J Clin Med 2021;10:1419. [PMID: 33915929 DOI: 10.3390/jcm10071419] [Reference Citation Analysis]
84 Mahmud N, Asrani SK, Reese PP, Kaplan DE, Taddei TH, Nadim MK, Serper M. Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis. Dig Dis Sci 2021. [PMID: 33761091 DOI: 10.1007/s10620-021-06943-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Jitwongwai S, Lertudomphonwanit C, Junhasavasdikul T, Fuangfa P, Tanpowpong P, Gesprasert G, Treepongkaruna S. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation. Pediatr Transplant 2021;25:e13996. [PMID: 33734542 DOI: 10.1111/petr.13996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
86 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
87 West J, Gow PJ, Testro A, Chapman B, Sinclair M. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review. J Gastroenterol Hepatol 2021. [PMID: 33638197 DOI: 10.1111/jgh.15474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
88 Woolfson JP, Perez M, Chavhan GB, Johara FT, Lurz E, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease on the Transplant Waiting List. Liver Transpl 2021;27:641-51. [PMID: 33460522 DOI: 10.1002/lt.25985] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
89 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
90 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Cheung CL, Lee GK, Au PC, Li GH, Chan M, Li HL, Cheung BM, Wong IC, Lee VH, Mok J, Yip BH, Cheng KK, Wu CH. Systematic review and meta-analysis of lean mass and mortality: Rationale and study description. Osteoporos Sarcopenia 2021;7:S3-S12. [PMID: 33997303 DOI: 10.1016/j.afos.2021.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
92 Bhanji RA, Saiman Y, Watt KD. Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation. Clin Liver Dis (Hoboken) 2021;17:2-5. [PMID: 33552477 DOI: 10.1002/cld.1000] [Reference Citation Analysis]
93 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
94 Jang HY, Choi GH, Hwang SH, Jang ES, Kim JW, Ahn JM, Choi Y, Cho JY, Han HS, Lee J, Chung JW, Baeg JY, Jeong SH. Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection. Transl Cancer Res 2021;10:854-66. [PMID: 35116415 DOI: 10.21037/tcr-20-2974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, Ulmer TF, Bruners P, Strnad P, Trautwein C, von Websky MW, Tacke F, Neumann UP, Lurje G. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle 2021;12:358-67. [PMID: 33525056 DOI: 10.1002/jcsm.12669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
96 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:86. [PMID: 33504046 DOI: 10.3390/life11020086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
97 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel). 2021;11. [PMID: 33504046 DOI: 10.3390/life11020086.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Marasco G, Sadalla S, Vara G, Golfieri R, Festi D, Colecchia A, Renzulli M. Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol. 2021;2021:6669480. [PMID: 33505942 DOI: 10.1155/2021/6669480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
99 Hughes CB, Humar A. Liver transplantation: current and future. Abdom Radiol (NY) 2021;46:2-8. [PMID: 31953588 DOI: 10.1007/s00261-019-02357-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
100 Johnston HE, de Crom T, Hargrave C, Adhyaru P, Woodward AJ, Pang S, Ali A, Coombes JS, Keating SE, McLean K, Mayr HL, Macdonald GA, Hickman IJ. The inter- and intrarater reliability and feasibility of dietetic assessment of sarcopenia and frailty in potential liver transplant recipients: A mixed-methods study. Clin Transplant 2021;35:e14185. [PMID: 33306855 DOI: 10.1111/ctr.14185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
101 Benmassaoud A, Roccarina D, Arico F, Leandro G, Yu B, Cheng F, Yu D, Patch D, Tsochatzis E. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. Am J Gastroenterol 2020;115:1911-4. [PMID: 33156111 DOI: 10.14309/ajg.0000000000000959] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
102 Anand A, Sharma S, Saraya A. Low skeletal muscle mass and significant fibrosis in non-alcoholic fatty liver disease: Cause or effect? Liver Int 2021;41:1160. [PMID: 33249727 DOI: 10.1111/liv.14746] [Reference Citation Analysis]
103 Marasco G, Dajti E, Ravaioli F, Brocchi S, Rossini B, Alemanni LV, Peta G, Bartalena L, Golfieri R, Festi D, Colecchia A, Renzulli M. Clinical impact of sarcopenia assessment in patients with liver cirrhosis. Expert Rev Gastroenterol Hepatol 2021;15:377-88. [PMID: 33196344 DOI: 10.1080/17474124.2021.1848542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
104 Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 2021;41:494-504. [PMID: 33164304 DOI: 10.1111/liv.14719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
105 Ebadi M, Bhanji RA, Dunichand-Hoedl AR, Mazurak VC, Baracos VE, Montano-Loza AJ. Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis. Nutrients. 2020;12:3463. [PMID: 33187310 DOI: 10.3390/nu12113463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
106 Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A, Sabry A. Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients. Asian Pac J Cancer Prev 2020;21:3285-90. [PMID: 33247686 DOI: 10.31557/APJCP.2020.21.11.3285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
107 Thompson C, Taleban S. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal Disease. Curr Treat Options Gastro 2020;18:635-56. [DOI: 10.1007/s11938-020-00310-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Cillo U, De Carlis L, Del Gaudio M, De Simone P, Fagiuoli S, Lupo F, Tisone G, Volpes R. Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group. Hepatol Int 2020;14:930-43. [PMID: 33099753 DOI: 10.1007/s12072-020-10091-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
109 Pita A, Ziogas IA, Ye F, Chen Y, Rauf MA, Matsuoka LK, Kaur N, Whang G, Zielsdorf SM, Bastas G, Izzy M, Alexopoulos SP. Feasibility of Serial Ultrasound Measurements of the Rectus Femoris Muscle Area to Assess Muscle Loss in Patients Awaiting Liver Transplantation in the Intensive Care Unit. Transplant Direct 2020;6:e618. [PMID: 33134494 DOI: 10.1097/TXD.0000000000001067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
110 Mauro E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, Diaz JM, Saidman J, Bermudez C, Ortiz-Patron J, Garcia-Olveira L, Zalazar F, Narvaez A, Spina JC, Orta R, Savluk L, Piano S, Marciano S, Gadano A. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List. Transplantation. 2020;104:e188-e198. [PMID: 32150034 DOI: 10.1097/tp.0000000000003222] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
111 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
112 Goto S, Arimoto J, Higurashi T, Takahashi K, Ohkubo N, Kawamura N, Tamura T, Tomonari H, Iwasaki A, Taniguchi L, Chiba H, Atsukawa K, Saigusa Y, Nakajima A. Efficacy and safety of colorectal endoscopic submucosal dissection in patients with sarcopenia. Surg Endosc 2021;35:5489-96. [PMID: 32989535 DOI: 10.1007/s00464-020-08041-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
114 Wang NC, Zhang P, Tapper EB, Saini S, Wang SC, Su GL. Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease. Am J Gastroenterol. 2020;115:1210-1216. [PMID: 32467506 DOI: 10.14309/ajg.0000000000000662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
115 Fozouni L, Wang CW, Lai JC. Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis. Clin Transl Gastroenterol 2019;10:e00102. [PMID: 31789932 DOI: 10.14309/ctg.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
116 Ishida Y, Maeda K, Yamanaka Y, Matsuyama R, Kato R, Yamaguchi M, Nonogaki T, Shimizu A, Ueshima J, Murotani K, Mori N. Formula for the Cross-Sectional Area of the Muscles of the Third Lumbar Vertebra Level from the Twelfth Thoracic Vertebra Level Slice on Computed Tomography. Geriatrics (Basel) 2020;5:E47. [PMID: 32899577 DOI: 10.3390/geriatrics5030047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
117 Ruiz-Margáin A, Xie JJ, Román-Calleja BM, Pauly M, White MG, Chapa-Ibargüengoitia M, Campos-Murguía A, González-Regueiro JA, Macias-Rodríguez RU, Duarte-Rojo A. Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites. Clin Gastroenterol Hepatol 2021;19:1941-1949.e2. [PMID: 32890753 DOI: 10.1016/j.cgh.2020.08.066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
118 Santhakumar C, Bartlett AS, Plank LD, Wells CI, Wu LY, Gane EJ, Mccall JL. Sarcopenia negatively impacts long‐term outcomes following curative resection for hepatocellular carcinoma: Results of a long‐term follow‐up study. GastroHep 2020;2:215-223. [DOI: 10.1002/ygh2.412] [Reference Citation Analysis]
119 Ooi PH, Mazurak VC, Bhargava R, Dunichand‐hoedl A, Ayala Romero R, Gilmour SM, Yap JY, Mager DR. Myopenia and Reduced Subcutaneous Adiposity in Children With Liver Disease Are Associated With Adverse Outcomes. Journal of Parenteral and Enteral Nutrition 2021;45:961-72. [DOI: 10.1002/jpen.1963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Kappus MR, Wegermann K, Bozdogan E, Patel YA, Janas G, Shropshire E, Parish A, Niedzwiecki D, Muir AJ, Bashir M. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease. Liver Transpl 2020;26:1090-9. [PMID: 32433802 DOI: 10.1002/lt.25802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
121 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
122 Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol 2019;10:e00025. [PMID: 30939488 DOI: 10.14309/ctg.0000000000000025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 22.5] [Reference Citation Analysis]
123 Steggerda JA, Mahendraraj K, Todo T, Noureddin M. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. World J Gastroenterol 2020; 26(28): 4018-4035 [PMID: 32821068 DOI: 10.3748/wjg.v26.i28.4018] [Reference Citation Analysis]
124 Haugen CE, McAdams-DeMarco M, Verna EC, Rahimi RS, Kappus MR, Dunn MA, Volk ML, Gurakar A, Duarte-Rojo A, Ganger DR, O'Leary JG, Ladner D, Garonzik-Wang J, Segev DL, Lai JC. Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index. JAMA Surg 2019;154:1103-9. [PMID: 31509169 DOI: 10.1001/jamasurg.2019.2845] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
125 Ebadi M, Bhanji RA, Tandon P, Mazurak V, Baracos VE, Montano-Loza AJ. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment Pharmacol Ther 2020;52:600-18. [PMID: 32621329 DOI: 10.1111/apt.15927] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
126 Kuo SZ, Ahmad M, Dunn MA, Montano-Loza AJ, Carey EJ, Lin S, Moghe A, Chen HW, Ebadi M, Lai JC. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation 2019;103:2312-7. [PMID: 30985575 DOI: 10.1097/TP.0000000000002741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
127 Merli M, Lattanzi B, Aprile F. Sarcopenic obesity in fatty liver. Curr Opin Clin Nutr Metab Care 2019;22:185-90. [PMID: 30893090 DOI: 10.1097/MCO.0000000000000558] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
128 Esser H, Resch T, Pamminger M, Mutschlechner B, Troppmair J, Riedmann M, Gassner E, Maglione M, Margreiter C, Boesmueller C, Oberhuber R, Weissenbacher A, Cardini B, Finkenstedt A, Zoller H, Tilg H, Öfner D, Schneeberger S. Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation. Transplantation 2019;103:2506-14. [PMID: 30985737 DOI: 10.1097/TP.0000000000002759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
129 Rachakonda V, Argemi J, Borhani AA, Bataller R, Tevar A, Behari J. Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00013. [PMID: 30908309 DOI: 10.14309/ctg.0000000000000013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
130 Zambrano DN, Xiao J, Prado CM, Gonzalez MC. Patient-Generated Subjective Global Assessment and Computed Tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: Is there any association? Clinical Nutrition 2020;39:1535-40. [DOI: 10.1016/j.clnu.2019.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
131 Dhaliwal A, Williams FR, El-sherif O, Armstrong MJ. Sarcopenia in Liver Transplantation: an Update. Curr Hepatology Rep 2020;19:128-37. [DOI: 10.1007/s11901-020-00515-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Barbero-Becerra VJ, López-Méndez I, Romo-Araiza A, Visag-Castillo V, Chávez-Tapia NC, Uribe M, Juárez-Hernandez E. Sarcopenia in chronic liver diseases: a translational overview. Expert Rev Gastroenterol Hepatol 2020;14:355-66. [PMID: 32299261 DOI: 10.1080/17474124.2020.1757427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Vural A, Attaway A, Welch N, Zein J, Dasarathy S. Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients. Clin Nutr 2020;39:3711-20. [PMID: 32303380 DOI: 10.1016/j.clnu.2020.03.032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
134 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Shimizu M. Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis. J Clin Med 2020;9:E1013. [PMID: 32260139 DOI: 10.3390/jcm9041013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
135 Salim TI, Nestlerode LC, Lucatorto EL, Wasserman TL, Din HA, Landsittel DP, Tevar AD, Johnson JT, Duarte-rojo A, Dunn MA. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications. Am J Gastroenterol 2020;115:859-66. [DOI: 10.14309/ajg.0000000000000609] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
136 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Reply to "Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.". Nutrients 2020;12:E869. [PMID: 32213917 DOI: 10.3390/nu12030869] [Reference Citation Analysis]
137 Ebadi M, Moctezuma-Velazquez C, Bhanji RA, Montano-Loza AJ. Reliable Measures of Sarcopenia in Cirrhosis. Comment on: "The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097". Nutrients 2020;12:E875. [PMID: 32213954 DOI: 10.3390/nu12030875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
139 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Hou L, Deng Y, Wu H, Xu X, Lin L, Cui B, Zhao T, Fan X, Mao L, Hou J, Sun H, Wang B, Sun C. Low psoas muscle index associates with long-term mortality in cirrhosis: construction of a nomogram. Ann Transl Med 2020;8:358. [PMID: 32355802 DOI: 10.21037/atm.2020.02.49] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
141 Romagna ES, Appel-da-silva MC, Suwa E, Maeda FK, Mattos AAD, Tovo CV. Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study. Sao Paulo Med J 2020;138:152-157. [DOI: 10.1590/1516-3180.2019.0436.r1.19122019] [Reference Citation Analysis]
142 Ghufran A. Nutrition in Chronic Liver Disease: A Point-of-Care Review. Nutr Clin Pract. 2020;35:211-217. [PMID: 32092183 DOI: 10.1002/ncp.10470] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
143 El Sherif O, Dhaliwal A, Newsome PN, Armstrong MJ. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. Expert Rev Gastroenterol Hepatol 2020;14:197-205. [PMID: 32064966 DOI: 10.1080/17474124.2020.1731303] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
144 Traub J, Bergheim I, Eibisberger M, Stadlbauer V. Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019. Nutrients. 2020;12:547. [PMID: 32093198 DOI: 10.3390/nu12020547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
145 Idriss R, Hasse J, Wu T, Khan F, Saracino G, McKenna G, Testa G, Trotter J, Klintmalm G, Asrani SK. Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes. Liver Transpl. 2019;25:217-227. [PMID: 30369002 DOI: 10.1002/lt.25368] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
146 Modesto AE, Stuart CE, Cho J, Ko J, Singh RG, Petrov MS. Psoas muscle size as a magnetic resonance imaging biomarker of progression of pancreatitis. Eur Radiol 2020;30:2902-11. [DOI: 10.1007/s00330-019-06633-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
147 Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res 2020;9:F1000 Faculty Rev-97. [PMID: 32089834 DOI: 10.12688/f1000research.20394.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
148 Ebadi M, Moctezuma-Velazquez C, Meza-Junco J, Baracos VE, DunichandHoedl AR, Ghosh S, Sarlieve P, Owen RJ, Kneteman N, Montano-Loza AJ. Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy. Cancers (Basel) 2020;12:E356. [PMID: 32033166 DOI: 10.3390/cancers12020356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
149 Schulze-Hagen M, Truhn D, Duong F, Keil S, Pedersoli F, Kuhl CK, Lurje G, Neumann U, Isfort P, Bruners P, Zimmermann M. Correlation Between Sarcopenia and Growth Rate of the Future Liver Remnant After Portal Vein Embolization in Patients with Colorectal Liver Metastases. Cardiovasc Intervent Radiol 2020;43:875-81. [PMID: 31974746 DOI: 10.1007/s00270-020-02416-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
150 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 18.5] [Reference Citation Analysis]
151 Gonzalez MC, Xiao J, Disi IR. Sex-, Age-, and Ethnicity-Dependent Variation in Body Composition: Can There Be a Single Cutoff? Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_8] [Reference Citation Analysis]
152 Purdy GM, Riess KJ, Ismond KP, Tandon P. Exercise Training in Patients with Cirrhosis. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_7] [Reference Citation Analysis]
153 Kappus MR, Barman P. Muscle Mass Versus Muscle Strength and Performance: Is Muscle Mass Measurement Alone Enough? Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_9] [Reference Citation Analysis]
154 Montano-loza AJ, Ebadi M. Definition and Diagnosis of Sarcopenia in the Research and Clinical Settings. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Dasarathy S. The Pathogenesis of Physical Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Dunn MA. A Research Wish List to Understand, Diagnose, and Manage Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_18] [Reference Citation Analysis]
157 Bhanji RA, Carey EJ. Physical Frailty and Sarcopenia in End-Stage Liver Disease: Do They Improve After Liver Transplantation? Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_13] [Reference Citation Analysis]
158 Sonnenday CJ. Frailty and Sarcopenia in the Selection of Candidates for Liver Transplantation. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_12] [Reference Citation Analysis]
159 Buettner S, Ijzermans JNM, van Vugt JLA. Prognostic Implications of Physical Frailty and Sarcopenia Pre and Post Transplantation. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_5] [Reference Citation Analysis]
160 Bhanji RA, Narayanan P, Moynagh MR, Takahashi N, Angirekula M, Kennedy CC, Mara KC, Dierkhising RA, Watt KD. Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease. Liver Transpl. 2019;25:14-24. [PMID: 30257063 DOI: 10.1002/lt.25346] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 14.7] [Reference Citation Analysis]
161 Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, Gow PJ. Reply. Liver Transpl 2020;26:309-10. [PMID: 31833637 DOI: 10.1002/lt.25700] [Reference Citation Analysis]
162 Abrigo J, Marín T, Aguirre F, Tacchi F, Vilos C, Simon F, Arrese M, Cabrera D, Cabello-verrugio C. N-Acetyl Cysteine Attenuates the Sarcopenia and Muscle Apoptosis Induced by Chronic Liver Disease. CMM 2019;20:60-71. [DOI: 10.2174/1566524019666190917124636] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
163 Bhanji RA, Montano-Loza AJ, Watt KD. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease. Hepatology 2019;70:2193-203. [PMID: 31034656 DOI: 10.1002/hep.30686] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
164 Moctezuma-velazquez C, Ebadi M, Bhanji RA, Stirnimann G, Tandon P, Montano-loza AJ. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis. Clinical Nutrition 2019;38:2696-703. [DOI: 10.1016/j.clnu.2018.11.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
165 Georgiou A, Papatheodoridis GV, Alexopoulou A, Deutsch M, Vlachogiannakos I, Ioannidou P, Papageorgiou MV, Papadopoulos N, Yannakoulia M, Kontogianni MD. Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study. Ann Gastroenterol. 2020;33:80-86. [PMID: 31892802 DOI: 10.20524/aog.2019.0432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
166 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 59] [Cited by in F6Publishing: 71] [Article Influence: 19.7] [Reference Citation Analysis]
167 Ebadi M, Montano-loza AJ. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. Digestive and Liver Disease 2019;51:1493-9. [DOI: 10.1016/j.dld.2019.05.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
168 Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, Riggio O. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology 2019;70:1704-13. [PMID: 31038758 DOI: 10.1002/hep.30692] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 18.3] [Reference Citation Analysis]
169 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 112] [Cited by in F6Publishing: 117] [Article Influence: 37.3] [Reference Citation Analysis]
170 Reddy YK, Maliakkal B, Agbim U. Nutrition in Chronic Liver Disease. Curr Treat Options Gastro 2019;17:602-18. [DOI: 10.1007/s11938-019-00252-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
171 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
172 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis. Hepatol Res 2019;49:1414-26. [PMID: 31408558 DOI: 10.1111/hepr.13420] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
173 Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D'Ambrosio D, Gioia S, Ginanni Corradini S, Lucidi C, Mennini G, Rossi M, Merli M, Riggio O. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. Dig Liver Dis 2019;51:1508-12. [PMID: 31601536 DOI: 10.1016/j.dld.2019.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
174 Mouzaki M, Bronsky J, Gupte G, Hojsak I, Jahnel J, Pai N, Quiros-tejeira RE, Wieman R, Sundaram S. Nutrition Support of Children With Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 2019;69:498-511. [DOI: 10.1097/mpg.0000000000002443] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
175 Becchetti C, Bosch J. Muscle abnormalities in cirrhosis: Calling for more strength in evaluation and prevention. Dig Liver Dis 2019;51:1500-1. [PMID: 31542219 DOI: 10.1016/j.dld.2019.08.015] [Reference Citation Analysis]
176 Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol 2019; 25(35): 5257-5265 [PMID: 31558871 DOI: 10.3748/wjg.v25.i35.5257] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
177 Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int. 2019;39:2374-2385. [PMID: 31421002 DOI: 10.1111/liv.14217] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
178 Kang SH, Jeong WK, Baik SK, Cha SH, Kim MY. Impact of sarcopenia on prognostic value of cirrhosis: Going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle. 2018;9:860-870. [PMID: 30371017 DOI: 10.1002/jcsm.12333] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
179 Dhaliwal A, Towey J, Lord JM, Armstrong M, Elsharkawy AM. Nutrition in liver cirrhosis: a case-based overview. Frontline Gastroenterol 2020;11:155-61. [PMID: 32133115 DOI: 10.1136/flgastro-2018-101121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
180 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation. Nutrients. 2019;11. [PMID: 31487854 DOI: 10.3390/nu11092097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
181 Jeong HM, Kim DJ. Bone Diseases in Patients with Chronic Liver Disease. Int J Mol Sci. 2019;20. [PMID: 31480433 DOI: 10.3390/ijms20174270] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
182 Barman PM, Patel YA. Getting a "Grip" on Sarcopenia for the Liver Transplant Candidate: Time to Focus on Muscle Function. Liver Transpl 2019;25:1475-6. [PMID: 31433898 DOI: 10.1002/lt.25625] [Reference Citation Analysis]
183 Theodoridis X, Grammatikopoulou MG, Petalidou A, Kontonika S, Potamianos SP, Bogdanos DP. A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree? Nutrition in Clinical Practice 2020;35:98-107. [DOI: 10.1002/ncp.10393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
184 Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019;54:845-59. [PMID: 31392488 DOI: 10.1007/s00535-019-01605-6] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 28.0] [Reference Citation Analysis]
185 Storck LJ, Imoberdorf R, Ballmer PE. Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease. J Clin Med 2019;8:E1098. [PMID: 31349549 DOI: 10.3390/jcm8081098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
186 Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, Mager DR. Sarcopenia in Chronic Liver Disease: Impact on Outcomes. Liver Transpl. 2019;25:1422-1438. [PMID: 31242345 DOI: 10.1002/lt.25591] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 17.0] [Reference Citation Analysis]
187 Tapper EB, Derstine B, Baki J, Su GL. Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci. 2019;. [PMID: 31292783 DOI: 10.1007/s10620-019-05713-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
188 Palmer LB, Kuftinec G, Pearlman M, Green CH. Nutrition in Cirrhosis. Curr Gastroenterol Rep. 2019;21:38. [PMID: 31289936 DOI: 10.1007/s11894-019-0706-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
189 Rodrigues SG, Brabandt B, Stirnimann G, Maurer MH, Berzigotti A. Adipopenia correlates with higher portal pressure in patients with cirrhosis. Liver Int. 2019;39:1672-1681. [PMID: 31207018 DOI: 10.1111/liv.14175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
190 Lattanzi B, Gioia S, Di Cola S, D'Ambrosio D, Nardelli S, Tavano D, Farcomeni A, Merli M, Riggio O. Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension. Liver Int 2019;39:1937-42. [PMID: 31152475 DOI: 10.1111/liv.14160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
191 Kohi MP, Lai JC. Impact of Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation on Patients Awaiting Liver Transplantation. J Vasc Interv Radiol 2019;30:874-5. [PMID: 31126599 DOI: 10.1016/j.jvir.2019.02.006] [Reference Citation Analysis]
192 Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019;61:93-8. [DOI: 10.1016/j.nut.2018.10.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
193 Jahangiri Y, Pathak P, Tomozawa Y, Li L, Schlansky BL, Farsad K. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis. J Vasc Interv Radiol. 2019;30:866-872.e4. [PMID: 31053265 DOI: 10.1016/j.jvir.2019.01.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
194 Moctezuma-Velázquez C, Low G, Mourtzakis M, Ma M, Burak KW, Tandon P, Montano-Loza AJ. Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study. Ann Hepatol 2018;17:615-23. [PMID: 29893704 DOI: 10.5604/01.3001.0012.0930] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
195 Gao B, Xiao J, Zhang M, Zhang F, Zhang W, Yang J, He J, Liu Y, Zou X, Xu P, Zhuge Y. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study. Lipids Health Dis 2019;18:79. [PMID: 30927926 DOI: 10.1186/s12944-019-1005-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
196 Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P, Chapman B, Gow PJ. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int 2019;39:1089-97. [PMID: 30746903 DOI: 10.1111/liv.14071] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
197 Feng Z, Rong P, Luo M, Sun X, Wang W. Influence of Methods Used to Establish Sarcopenia Cutoff Values for Skeletal Muscle Measures Using Unenhanced and Contrast-Enhanced Computed Tomography Images. JPEN J Parenter Enteral Nutr 2019;43:1028-36. [PMID: 30741436 DOI: 10.1002/jpen.1519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
198 Gioia S, Merli M, Nardelli S, Lattanzi B, Pitocchi F, Ridola L, Riggio O. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int. 2019;39:871-877. [PMID: 30667572 DOI: 10.1111/liv.14050] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
199 Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, Dierkhising RA, Watt KD. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther 2019;49:807-13. [PMID: 30714184 DOI: 10.1111/apt.15161] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
200 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
201 Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Bischoff SC. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019;38:485-521. [PMID: 30712783 DOI: 10.1016/j.clnu.2018.12.022] [Cited by in Crossref: 237] [Cited by in F6Publishing: 250] [Article Influence: 79.0] [Reference Citation Analysis]
202 Wells CI, Mccall JL, Plank LD. Relationship Between Total Body Protein and Cross‐Sectional Skeletal Muscle Area in Liver Cirrhosis Is Influenced by Overhydration. Liver Transpl 2019;25:45-55. [DOI: 10.1002/lt.25314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
203 Engelmann C, Schob S, Nonnenmacher I, Werlich L, Aehling N, Ullrich S, Kaiser T, Krohn S, Herber A, Sucher R, Bartels M, Surov A, Hasenclever D, Kahn T, Seehofer D, Moche M, Berg T. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death. Aliment Pharmacol Ther 2018;48:1271-81. [DOI: 10.1111/apt.15026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
204 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 22.0] [Reference Citation Analysis]
205 Price KL, Earthman CP. Update on body composition tools in clinical settings: computed tomography, ultrasound, and bioimpedance applications for assessment and monitoring. Eur J Clin Nutr 2019;73:187-93. [DOI: 10.1038/s41430-018-0360-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
206 Hsu C, Kao J. Sarcopenia and chronic liver diseases. Expert Review of Gastroenterology & Hepatology 2018;12:1229-44. [DOI: 10.1080/17474124.2018.1534586] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 10.8] [Reference Citation Analysis]
207 Ebadi M, Wang CW, Lai JC, Dasarathy S, Kappus MR, Dunn MA, Carey EJ, Montano-Loza AJ;  From the Fitness; Life Enhancement;  and Exercise in Liver Transplantation (FLEXIT) Consortium. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J Cachexia Sarcopenia Muscle. 2018;9:1053-1062. [PMID: 30269421 DOI: 10.1002/jcsm.12349] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 16.0] [Reference Citation Analysis]
208 Stirnimann G, Ebadi M, Tandon P, Montano-Loza AJ. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication? Curr Gastroenterol Rep. 2018;20:50. [PMID: 30259203 DOI: 10.1007/s11894-018-0656-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
209 Chascsa DM, Lai JC, Dunn MA, Montano-Loza AJ, Kappus MR, Dasarathy S, Carey EJ. Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. Dig Dis Sci 2018;63:3290-6. [PMID: 30178285 DOI: 10.1007/s10620-018-5271-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
210 van Vugt JLA, van Putten Y, van der Kall IM, Buettner S, D'Ancona FCH, Dekker HM, Kimenai HJAN, de Bruin RWF, Warlé MC, IJzermans JNM. Estimated skeletal muscle mass and density values measured on computed tomography examinations in over 1000 living kidney donors. Eur J Clin Nutr 2019;73:879-86. [PMID: 30143785 DOI: 10.1038/s41430-018-0287-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
211 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-193. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 333] [Cited by in F6Publishing: 252] [Article Influence: 83.3] [Reference Citation Analysis]
212 Ohara M, Ogawa K, Suda G, Kimura M, Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ohnishi S, Sakamoto N. L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis. Hepatol Commun. 2018;2:906-918. [PMID: 30094402 DOI: 10.1002/hep4.1207] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 12.5] [Reference Citation Analysis]
213 Peng TC. Role of Sarcopenia in Nonalcoholic Fatty Liver Disease: Definition Is Crucially Important. Hepatology 2018;68:788-9. [PMID: 29604216 DOI: 10.1002/hep.29910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
214 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 25.3] [Reference Citation Analysis]
215 Mager DR, Hager A, Ooi PH, Siminoski K, Gilmour SM, Yap JY. Persistence of Sarcopenia After Pediatric Liver Transplantation Is Associated With Poorer Growth and Recurrent Hospital Admissions. Journal of Parenteral and Enteral Nutrition 2019;43:271-80. [DOI: 10.1002/jpen.1414] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
216 Merli M, Durand F. Muscle mass vs. adipose tissue to predict outcome in cirrhosis: Which matters and in which patients? J Hepatol 2018;69:567-9. [PMID: 30122221 DOI: 10.1016/j.jhep.2018.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
217 Campos F, Abrigo J, Aguirre F, Garcés B, Arrese M, Karpen S, Cabrera D, Andía ME, Simon F, Cabello-verrugio C. Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin–proteasome system and oxidative stress. Pflugers Arch - Eur J Physiol 2018;470:1503-19. [DOI: 10.1007/s00424-018-2167-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
218 Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A, Ebadi M, Ghosh S, Rose C, Montano-Loza AJ. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int. 2018;12:377-386. [PMID: 29881992 DOI: 10.1007/s12072-018-9875-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 22.3] [Reference Citation Analysis]
219 Lattanzi B, D’ambrosio D, Fedele V, Merli M. Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis. Curr Hepatology Rep 2018;17:88-96. [DOI: 10.1007/s11901-018-0398-6] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
220 Eslamparast T, Montano-loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans. Liver Int 2018;38:1706-17. [DOI: 10.1111/liv.13876] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 16.3] [Reference Citation Analysis]
221 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
222 Lattanzi B, D'Ambrosio D, Merli M. Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration. J Clin Exp Hepatol. 2019;9:125-130. [PMID: 30765945 DOI: 10.1016/j.jceh.2018.04.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
223 Silva LD, Bering T, Rocha GA. The impact of nutrition on quality of life of patients with hepatitis C. Curr Opin Clin Nutr Metab Care 2017;20:420-5. [PMID: 28617708 DOI: 10.1097/MCO.0000000000000396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
224 Ebadi M, Tandon P, Moctezuma-Velazquez C, Ghosh S, Baracos VE, Mazurak VC, Montano-Loza AJ. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol. 2018;69:608-616. [PMID: 29709682 DOI: 10.1016/j.jhep.2018.04.015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 18.0] [Reference Citation Analysis]
225 Ebadi M, Montano-loza AJ. Insights on clinical relevance of sarcopenia in patients with cirrhosis and sepsis. Liver Int 2018;38:786-8. [DOI: 10.1111/liv.13720] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
226 van Vugt JLA, Alferink LJM, Buettner S, Metselaar HJ, IJzermans JNM. Reply to: "May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?" and "Has the time come for using MELD-Sarcopenia score?". J Hepatol 2018;68:1326. [PMID: 29625828 DOI: 10.1016/j.jhep.2018.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
227 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
228 Praktiknjo M, Book M, Luetkens J, Pohlmann A, Meyer C, Thomas D, Jansen C, Feist A, Chang J, Grimm J, Lehmann J, Strassburg CP, Abraldes JG, Kukuk G, Trebicka J. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 2018;67:1014-26. [PMID: 29059469 DOI: 10.1002/hep.29602] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 20.8] [Reference Citation Analysis]
229 Chen HW, Dunn MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects. Clin Liver Dis (Hoboken) 2018;11:52-7. [PMID: 30992788 DOI: 10.1002/cld.691] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
230 Huguet A, Latournerie M, Debry PH, Jezequel C, Legros L, Rayar M, Boudjema K, Guyader D, Jacquet EB, Thibault R. The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: A retrospective cohort study. Nutrition 2018;51-52:73-9. [PMID: 29605767 DOI: 10.1016/j.nut.2018.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
231 Dunn MA. The cost of sarcopenia. Transpl Int 2018;31:155-6. [DOI: 10.1111/tri.13069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
232 van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol. 2018;68:707-714. [PMID: 29221886 DOI: 10.1016/j.jhep.2017.11.030] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 18.8] [Reference Citation Analysis]
233 Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology 2017;66:2055-65. [PMID: 28777879 DOI: 10.1002/hep.29420] [Cited by in Crossref: 128] [Cited by in F6Publishing: 137] [Article Influence: 25.6] [Reference Citation Analysis]
234 Maeda K, Saiki Y. Reconsideration of frailty in relation to surgical indication. Gen Thorac Cardiovasc Surg 2018;66:201-13. [PMID: 29170898 DOI: 10.1007/s11748-017-0869-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Mazurak VC, Tandon P, Montano-loza AJ. Nutrition and the transplant candidate: Mazurak et al. Liver Transpl 2017;23:1451-64. [DOI: 10.1002/lt.24848] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
236 Bhanji RA, Carey EJ, Yang L, Watt KD. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist. Clinical Gastroenterology and Hepatology 2017;15:1492-7. [DOI: 10.1016/j.cgh.2017.04.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
237 van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ, Ijzermans JNM. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018;31:165-74. [DOI: 10.1111/tri.13048] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
238 Dasarathy J, McCullough AJ, Dasarathy S. Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances. Alcohol Clin Exp Res. 2017;41:1419-1431. [PMID: 28557005 DOI: 10.1111/acer.13425] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
239 Nishikawa H, Nishimura T, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Takata R, Hasegawa K, Nakano C, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Nishiguchi S, Iijima H. Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases. Nutrients 2017;9:E620. [PMID: 28621757 DOI: 10.3390/nu9060620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]